Hofseth Biocare ASA (0Q6H) Share Price & Analysis

0Q6H Stock Chart & Stats

NOK 1.31NOK 0.00(0.00%)

At close: Oct 30 12:00 AM GMT

Day’s Range: NOK 1.31 - NOK 1.31
52-Week Range: NOK 1.28 - NOK 1.80
Previous Close: NOK 1.31
Volume: N/A
Average Volume (3M): 1,093
Market Cap: NOK 618.85M
Enterprise Value: NOK 797.22M
Total Cash (Recent Filing): NOK 71.95M
Total Debt (Recent Filing): NOK 236.19M
Price to Earnings (P/E): ―
Beta: 0.57
Next Earnings: Nov 06, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Hofseth Biocare ASA News

Hofseth Biocare Targets Joint Health Upside With New Salmon Oil–Collagen Trial

Hofseth Biocare ASA ($HOFBF) announced an update on their ongoing clinical study. Hofseth Biocare ASA is preparing a new clinical trial to test whether a blend of whole salmon oil

2w agoHOFBF

Hofseth BioCare Secures NOK 144.5 Million as Listing Shares Join Main Oslo Market

Hofseth Biocare ASA ( ($HOFBF) ) just unveiled an update. Hofseth BioCare ASA, a Norwegian-listed producer of sustainable salmon-derived health ingredients for human and pet markets, continues to build its

3w agoHBQ HOFBF

Hofseth BioCare Board Member Boosts Stake with Major Share Purchase

Hofseth Biocare ASA ( ($HOFBF) ) has issued an announcement. Board member and primary insider Christoph Baldegger has increased his stake in Hofseth BioCare ASA with the purchase of 2.5

1M agoHBQ HOFBF

Hofseth Biocare Targets Menopause Market With New ProGo Clinical Trial

Hofseth Biocare ASA ($HOFBF) announced an update on their ongoing clinical study. The ProGo Menopause Wellbeing Study is a new trial led by Hofseth Biocare ASA to test whether its

2M agoHOFBF

Hofseth BioCare Elevates Long-Serving Executive to CFO Role

Hofseth Biocare ASA ( ($HOFBF) ) has provided an update. Hofseth BioCare ASA has appointed long-serving executive Leif Arne Giske as its new Chief Financial Officer for the HBC Group,

2M agoHBQ HOFBF

Hofseth BioCare lifts margins, prices and liquidity despite softer Q2 sales

Hofseth Biocare ASA ( ($HOFBF) ) has provided an update. Hofseth BioCare reported Q2 2026 operating revenue of NOK 65.7 million, slightly down year-on-year, but achieved this with about 44

2M agoHBQ HOFBF

IFM Fund Manager Builds 9.59% Stake in Hofseth Biocare

Hofseth Biocare ASA ( ($HOFBF) ) has provided an update. IFM Independent Fund Management AG, a Liechtenstein-based fund manager, has disclosed that it will hold 9.59% of the voting rights

2M agoHBQ HOFBF

Hofseth BioCare Capital Increase Dilutes Major Shareholder Below 5%

An update from Hofseth Biocare ASA ( ($HOFBF) ) is now available. Hofseth BioCare ASA has completed a share capital increase following the issuance of offer shares in a second

2M agoHBQ HOFBF

Anthony Hall Family Trust Passes 5% Ownership in Hofseth BioCare

An announcement from Hofseth Biocare ASA ( ($HOFBF) ) is now available. Research Corporation Pty Ltd, acting as trustee for the Anthony Hall Family Trust, has acquired 14,280,748 ordinary shares

3M agoHBQ HOFBF

Hofseth BioCare Shareholders Approve All Proposals at Extraordinary Meeting

Hofseth Biocare ASA ( ($HOFBF) ) just unveiled an update. Hofseth BioCare ASA has completed an Extraordinary General Meeting held on 30 July 2026, where all proposals were approved as

3M agoHBQ HOFBF

0Q6H FAQ

What was Hofseth Biocare ASA’s price range in the past 12 months?

Hofseth Biocare ASA lowest share price was kr 1.28 and its highest was kr 1.80 in the past 12 months.

What is Hofseth Biocare ASA’s market cap?

Hofseth Biocare ASA’s market cap is kr 618.85M.

When is Hofseth Biocare ASA’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Hofseth Biocare ASA’s earnings last quarter?

Hofseth Biocare ASA released its earnings results on Jun 30, 2026. The company reported -kr 0.057 earnings per share for the quarter.

Is Hofseth Biocare ASA overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Hofseth Biocare ASA pay dividends?

Hofseth Biocare ASA does not currently pay dividends.

What is Hofseth Biocare ASA’s EPS estimate?

Hofseth Biocare ASA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hofseth Biocare ASA have?

Hofseth Biocare ASA has 506,235,630 shares outstanding.

What happened to Hofseth Biocare ASA’s price movement after its last earnings report?

Hofseth Biocare ASA reported an EPS of -kr 0.057 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Hofseth Biocare ASA?

Currently, no hedge funds are holding shares in GB:0Q6H

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Hofseth Biocare ASA

Hofseth BioCare ASA, an international firm based in Norway, specializes in developing and supplying premium biomarine ingredients for both human and animal health. The company's product portfolio features various specialized offerings, including Brilliant salmon oil and OmeGo salmon oil, which promotes healthy cholesterol levels and supports cardiovascular well-being. ProGo, a salmon protein hydrolysate, serves as a rapidly assimilated protein supplement. For skeletal and joint health, Hofseth offers CalGo, a marine calcium powder. CollaGo, a collagen peptide powder, is designed to improve the appearance of hair, skin, and nails. Additionally, PetGo provides a non-soluble protein formulation. Distribution of these products is managed through a multi-channel approach, utilizing a network of distributors, agents, and its dedicated internal sales team. Hofseth BioCare also holds a significant research collaboration with Stanford University School of Medicine, focusing on pre-clinical and clinical studies related to conditions such as necrotizing enterocolitis and irritable bowel syndrome. Established in 2000, the company's main operations are based in Ålesund, Norway.

Hofseth Biocare ASA (0Q6H) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	3	3	14
Technical Analysis	3	3	2
Moving Averages	0	0	12

Technical Analysis >

Similar Stocks

Stocks similar to GB:0Q6H
Company	Price & Change	Follow
HOFBFHofseth Biocare ASA
KALYKali
NTRBNutriband
BNTXBioNTech SE
RGNXRegenXBio
FATEFate Therapeutics

Compare GB:0Q6H Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

0Q6H Stock Chart & Stats

Hofseth Biocare ASA News

Hofseth Biocare Targets Joint Health Upside With New Salmon Oil–Collagen Trial

Hofseth BioCare Secures NOK 144.5 Million as Listing Shares Join Main Oslo Market

Hofseth BioCare Board Member Boosts Stake with Major Share Purchase

Hofseth Biocare Targets Menopause Market With New ProGo Clinical Trial

Hofseth BioCare Elevates Long-Serving Executive to CFO Role

Hofseth BioCare lifts margins, prices and liquidity despite softer Q2 sales

IFM Fund Manager Builds 9.59% Stake in Hofseth Biocare

Hofseth BioCare Capital Increase Dilutes Major Shareholder Below 5%

Anthony Hall Family Trust Passes 5% Ownership in Hofseth BioCare

Hofseth BioCare Shareholders Approve All Proposals at Extraordinary Meeting

0Q6H FAQ

Company Description

Hofseth Biocare ASA

Hofseth Biocare ASA (0Q6H) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium